719MO A phase I/II study of rinatabart sesutecan (Rina-S) in patients with advanced ovarian or endometrial cancer

Eric Lee, Oladapo Yeku, Ira Winer, Erika Hamilton, Dominic Richardson, Jian Zhang, G.E. Konecny, Ian C. Anderson, Xiaohua Wu, Douglas W. Orr, Sandip Pravin Patel, Andrew Jewell, Jing Wang, A.I. Spira, A. Melnyk, Leigh G. Seamon, Edward Kavalerchik, Z. Chen, Eric Song, J.A. Call